Molecular Optimization Via Exercise (MOVE)
ConditionAging
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65-80
SponsorBuck Institute for Research on Aging
About this trial
This study is to investigate characteristics of muscle, blood, and urine samples from older adults (ages 65-80) who are either sedentary or athletes performing at an elite level for their age. This observational study will include bio-specimen collection, as well as physical and cognitive function testing and body composition.
Eligibility criteria
Qualifiers
Willing and able to provide consent to take part in the MOVE-1 Main Study.
Willing and able to attend study visits and comply with all procedures of study data collection visits.
Able to read and speak English well enough to provide informed consent and understand instructions.
Healthy adults between the age of 65 - 80 y.
Disqualifiers
Subject requires assistance with any activity of daily living, excluding continence.
Subject lives in an institutional setting (skilled nursing facility or residential care facility for the elderly).
Abnormal bleeding or coagulopathy (self-report): History of a bleeding disorder, wound healing disorder or clotting abnormality.
Female participants must be post-menopause.
Trial design
Treatments tested in this trial
- Observational
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov